A Patient-Centric Virtual Model for Real-World Evidence Studies

We understand the importance of decentralized clinical trial models, which can include hybrid or virtual elements in a study, to enhance the patient experience and increase trial retention. This case study discusses our work at Labcorp to support a drug development sponsor's FDA regulatory submission with a "siteless" approach through our network of Labcorp Patient Service Centers.